§ 130c Abs. 1 SGB V Repatha(R) Wirkstoff: Evolocumab ATC-Code: C10AX13
Tender information
TED EUMünchen, Germany
- Type
- 25
- Procedure
- neg-wo-call
- Ref. number
- 198753-2025
- CPV
- 33600000
Arzneimittelrabattvertrag § 130c Abs. 1 SGB V Repatha(R) Wirkstoff: Evolocumab ATC-Code: C10AX13